Test Bank for Rau's Respiratory Care Pharmacology
Respiratory Care Pharmacology - ANSWERSApplication of pharmacology to the treatment of
pulmonary disorders and, more broadly, critical care.
Pharmacology - ANSWERSthe study of drugs, including their origins, properties, and interactions
with living organisms
Pharmacokinetics - ANSWERSTime course and disposition of a drug in the body, based on its
absorption, distribution, metabolism, and elimination.
Pharmacodynamics - ANSWERSThe mechanism of drug action by which a drug molecule causes
its effect in the body
Toxicology - ANSWERSStudy of toxic substances and their pharmacologic actions, including
antidotes and poison control.
Generic Name - ANSWERSName assigned to a chemical when it appears that the chemical has
therapeutic use and the manufacturer wishes to market the drug.
Respiratory Syncytial Virus - ANSWERSA virus that causes the formation of syncytial asses in the
cells and may cause respiratory distress in young infants.
Pseudomonas Carinii - ANSWERSAn organism that causes Pseudomocystis pneumonia in
humans and is seen in immunosuppressed individuals, such as those infected with HIV
Therapeutics - ANSWERSArt of treating disease with drugs.
,Perscription - ANSWERSWritten order for a drug, along with any specific instructions for
compounding, dispersing, and taking the drug.
Code Name - ANSWERSName given to an experimental chemical that shows potential as a drug.
Chemical Name - ANSWERSName that indicates the drug's chemical structure.
Official Name - ANSWERSName is what the generic name becomes once it recieves official
approval.
Trade Name - ANSWERSName is the non-proprietary name (ex: Motrin, Tylenol)
USP-NF - ANSWERSOfficial source of information about drug standards if you want to obtain
information about medications, dietary supplements and medical devices. US FDA considers this
book the official standard for drugs marketed in the US.
Physician's Desk Reference - ANSWERSReference source that has lots of color charts that
identify drugs, lists manufacturers, and tells how the drugs work, when they are indicated and
contraindicated, and possible side effects.
Drug Facts and Comparisons - ANSWERSA subscription service that provides monthly
information on drug products and new releases.
Most of today's drugs come from chemical synthesis, but -----, -----, ------, also contain certain
active ingredients for drugs. - ANSWERSPlants, Minerals, and Animals.
Investigational New Drug (IND) approval process Phase 1: - ANSWERSSmall group of healthy
volunteers
, Investigational New Drug (IND) approval process Phase 2: - ANSWERSSmall group of people with
the disease the drug is intended to treat.
Investigational New Drug (IND) approval process Phase 3 - ANSWERSLarge, multicenter studies
to establish safety and efficacy.
After successful IND process, a new drug application is filed with the FDA, and a detailed
reporting system is in place for how many months? To track any problems that arise with the
drug's use. - ANSWERSSix
Therapeutic Potential : A - ANSWERSImportant therapeutic gain over other drugs.
Therapeutic Potential : AA - ANSWERSImportant therapeutic gain, indicated for patients with
AIDS; fast-track.
Therapeutic Potential : B - ANSWERSModest therapeutic gain.
Therapeutic Potential : C - ANSWERSLittle or no therapeutic gain.
Orphan Drug - ANSWERSA special category of drugs that have been identified to help treat
patients with rare diseases.
When referring to Orphan Drugs, what does the term "rare" mean? - ANSWERSDisease that
affects fewer than 200, 000 persons.
Nitric Oxide Gas - ANSWERSOrphan drug that respiratory clinicians use for the treatment of
persistent pulmonary hypertension of newborns.
Respiratory Care Pharmacology - ANSWERSApplication of pharmacology to the treatment of
pulmonary disorders and, more broadly, critical care.
Pharmacology - ANSWERSthe study of drugs, including their origins, properties, and interactions
with living organisms
Pharmacokinetics - ANSWERSTime course and disposition of a drug in the body, based on its
absorption, distribution, metabolism, and elimination.
Pharmacodynamics - ANSWERSThe mechanism of drug action by which a drug molecule causes
its effect in the body
Toxicology - ANSWERSStudy of toxic substances and their pharmacologic actions, including
antidotes and poison control.
Generic Name - ANSWERSName assigned to a chemical when it appears that the chemical has
therapeutic use and the manufacturer wishes to market the drug.
Respiratory Syncytial Virus - ANSWERSA virus that causes the formation of syncytial asses in the
cells and may cause respiratory distress in young infants.
Pseudomonas Carinii - ANSWERSAn organism that causes Pseudomocystis pneumonia in
humans and is seen in immunosuppressed individuals, such as those infected with HIV
Therapeutics - ANSWERSArt of treating disease with drugs.
,Perscription - ANSWERSWritten order for a drug, along with any specific instructions for
compounding, dispersing, and taking the drug.
Code Name - ANSWERSName given to an experimental chemical that shows potential as a drug.
Chemical Name - ANSWERSName that indicates the drug's chemical structure.
Official Name - ANSWERSName is what the generic name becomes once it recieves official
approval.
Trade Name - ANSWERSName is the non-proprietary name (ex: Motrin, Tylenol)
USP-NF - ANSWERSOfficial source of information about drug standards if you want to obtain
information about medications, dietary supplements and medical devices. US FDA considers this
book the official standard for drugs marketed in the US.
Physician's Desk Reference - ANSWERSReference source that has lots of color charts that
identify drugs, lists manufacturers, and tells how the drugs work, when they are indicated and
contraindicated, and possible side effects.
Drug Facts and Comparisons - ANSWERSA subscription service that provides monthly
information on drug products and new releases.
Most of today's drugs come from chemical synthesis, but -----, -----, ------, also contain certain
active ingredients for drugs. - ANSWERSPlants, Minerals, and Animals.
Investigational New Drug (IND) approval process Phase 1: - ANSWERSSmall group of healthy
volunteers
, Investigational New Drug (IND) approval process Phase 2: - ANSWERSSmall group of people with
the disease the drug is intended to treat.
Investigational New Drug (IND) approval process Phase 3 - ANSWERSLarge, multicenter studies
to establish safety and efficacy.
After successful IND process, a new drug application is filed with the FDA, and a detailed
reporting system is in place for how many months? To track any problems that arise with the
drug's use. - ANSWERSSix
Therapeutic Potential : A - ANSWERSImportant therapeutic gain over other drugs.
Therapeutic Potential : AA - ANSWERSImportant therapeutic gain, indicated for patients with
AIDS; fast-track.
Therapeutic Potential : B - ANSWERSModest therapeutic gain.
Therapeutic Potential : C - ANSWERSLittle or no therapeutic gain.
Orphan Drug - ANSWERSA special category of drugs that have been identified to help treat
patients with rare diseases.
When referring to Orphan Drugs, what does the term "rare" mean? - ANSWERSDisease that
affects fewer than 200, 000 persons.
Nitric Oxide Gas - ANSWERSOrphan drug that respiratory clinicians use for the treatment of
persistent pulmonary hypertension of newborns.
